Pravin Dugel - Feb 22, 2024 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role
Executive Chairman, Director
Signature
/s/ Donald Notman, Attorney-in-Fact for Pravin Dugel
Stock symbol
OCUL
Transactions as of
Feb 22, 2024
Transactions value $
$0
Form type
4
Date filed
2/26/2024, 08:07 PM
Previous filing
Feb 26, 2024
Next filing
May 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUL Common Stock Award $0 +855K $0.00 855K Feb 22, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUL Stock Option (Right to Buy) Award $0 +1.28M $0.00 1.28M Feb 22, 2024 Common Stock 1.28M $9.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 22, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal quarterly installments, beginning on the date of grant.
F2 Vests over four years, vesting in equal monthly installments beginning on the date the reporting person commenced employment with the Corporation.